Journey Medical Corp
DERM
Get informed when a big investor buys or sells
+ FollowMarket Cap$190.18M
Close$
$-5.57
178.2% downside
Current Fair Value
178.2% downsideOvervalued by 178.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $190.18 Million |
|---|---|
| Enterprise Value | $188.49 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.47 |
| Beta | 1.07 |
| Outstanding Shares | 27,305,028 |
Return
| Return on Equity | -31.10% |
|---|---|
| Return on Assets | -10.47% |
| Return on Invested Capital | -13.41% |
Valuation & Multiples
| P/E Ratio | -18.38 |
|---|---|
| PEG | 40.63 |
| Price to Sales | 3.56 |
| Price to Book Ratio | 7.12 |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | -26.18 |
| Enterprise Value to Net Income | -20 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 19, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$20.42 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.01
Average shareholder expectationRevenue Estimate
$18.36 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 10.76%▼ 37.62% |
|---|---|
| Total Invested | $20.80M▼ 62.66% |
| Investors Holding | 2▼ 70.00% |
ESG Score
No data